PS PeptideSuppliers.org Finding the right peptide supplier for you
CJC-1295 reference image
View supplier listing 15% off with code KING15
Peptide guide

CJC-1295 Peptide Guide & Supplier Listing Notes

Long-acting GHRH analog, often DAC-modified

Long-acting GHRH analog research

Growth hormone secretagogue research compounds Educational guide Supplier transparency
Back to directory Compare supplier pages

Research Areas

The main research domains where this compound appears most often.

The main research area for CJC-1295 is GH/IGF-1 axis stimulation. Studies have examined GH release, IGF-1 increases, half-life, and duration of endocrine response.

A second research area is pharmacokinetics. CJC-1295 is valuable because it illustrates how peptide engineering can extend duration through albumin binding. This makes it relevant to broader peptide-drug design discussions.

CJC-1295 is also a comparison compound. It is commonly compared with sermorelin, tesamorelin, and ipamorelin. the receptor and duration differences between these compounds.

Animal studies

What preclinical work has emphasized

Animal studies have evaluated CJC-1295 in models involving GHRH deficiency and growth. These models help illustrate the ability of long-acting GHRH analogs to stimulate GH and IGF-1 signaling over an extended period.

The limitation is that animal growth models do not translate directly into adult human body-composition outcomes. They are best used to explain mechanism and endocrine duration rather than broad claims.

Human studies

How much human evidence exists

Human studies of CJC-1295 have evaluated pharmacokinetics, pharmacodynamics, and endocrine effects. Research reported prolonged increases in growth hormone and IGF-1, helping define CJC-1295 as a long-acting GHRH analog.

The human evidence is important but not broad. It should be summarized as endocrine and pharmacology research rather than proof of wide-ranging benefits. Dose, population, monitoring, and study design all affect interpretation.

Current research status

Where the research stands now

CJC-1295 remains important in peptide education as a long-acting GHRH analog. Its research value is strongest for understanding peptide half-life extension, albumin binding, and GH/IGF-1 axis stimulation.

Current interest is mostly comparative and mechanistic. Readers often need help understanding how CJC-1295 differs from sermorelin, tesamorelin, ipamorelin, and growth hormone.

Browse suppliers Open peptide directory Read education guides Best peptide suppliers

Related Compounds

Closely related compounds frequently discussed within the same research category.

Sermorelin is related as a shorter-acting GHRH analog. Tesamorelin is related as another GHRH analog with specific clinical research. Ipamorelin is related through GH release but uses ghrelin receptor signaling. IGF-1 LR3 is downstream through IGF-1 biology.

Ipamorelin Sermorelin Tesamorelin Hexarelin
Supplier considerations

How to read supplier pages more carefully

CJC-1295 supplier listings should clearly state whether the compound is CJC-1295 with DAC or a non-DAC GHRH analog. Researchers should look for COAs, purity data, sequence identity, lot numbers, storage instructions, and research-use labeling. Naming clarity is especially important for this compound.

  • Look for batch-specific COAs instead of generic laboratory files reused across many listings.
  • Check whether the product name, concentration language, and batch references stay consistent from page to page.
  • Read storage and handling notes alongside the document links rather than treating the headline purity claim as enough.
  • Prefer supplier pages that keep research-use labeling, contact details, and policy pages easy to verify.

Linked supplier pages

Supplier pages that help compare naming, documentation access, batch references, and overall page clarity.

Supplier listing

Peptides Kingdom

This listing helps with checking naming, documentation access, storage language, and overall page clarity.

View supplier listing
15% off with code KING15

Frequently Asked Questions

Common questions drawn from the published literature and documentation context.

What is CJC-1295?

CJC-1295 is a synthetic long-acting GHRH analog studied for stimulating GH and IGF-1.

What does DAC mean?

DAC refers to the drug-affinity complex design associated with albumin binding and extended duration.

Is CJC-1295 the same as sermorelin?

No. Both are GHRH-related, but CJC-1295 was designed for longer duration.

How is CJC-1295 different from ipamorelin?

CJC-1295 activates GHRH receptors, while ipamorelin activates ghrelin receptors.

Does CJC-1295 have human research?

Yes. Human studies have evaluated pharmacokinetics, pharmacodynamics, and GH/IGF-1 response.

What is CJC-1295 studied for?

It is studied for GH release, IGF-1 elevation, half-life extension, and endocrine signaling.

Why is naming important with CJC-1295?

Some suppliers use CJC-1295 to refer to different GHRH analog versions, so documentation matters.

What should researchers check when comparing suppliers?

COAs, sequence identity, DAC/no-DAC labeling, purity data, and storage guidance.

References

Primary sources and clinical references cited in this overview.